2004
2月19日,宁波美诺华药业股份有限公司成立
On February 19, Ningbo Menovo Pharmaceutical Co.,Ltd. was set up.
7月13日,成立安徽美诺华药物化学有限公司
On July 13, Anhui Menovo Pharmaceutical Co.,Ltd. was set up.
2005
11月17日,成立浙江美诺华药物化学有限公司
On November 17, Zhejiang Menovo Pharmaceutical Co.,Ltd. was set up.
2007
5月22日,成立宁波联华进出口有限公司
On May 22, Ningbo Lianhua Import & Export Co.,Ltd. was set up.
2009
11月,成立香港联合亿贸进出口有限公司
In November, Hongkong United Billion Trade Import And Export Co.,Ltd. was set up.
2010
11月18日,成立宁波美诺华天康药业有限公司
On November 18, Ningbo Menovo Tiankang Pharmaceutical Co.,Ltd. was set up.
2012
4月6日,成立上海新五洲药业有限公司
On April 6, Shanghai New International Pharmaceutical Co.,Ltd. was set up.
7月31日,成立杭州新诺华医药有限公司
On July 31, Hangzhou Sinovo Medicine Co.,Ltd. was set up.
2013
11月8日,美诺华药物研究院组建成立
On November 8, Menovo R&D Center was set up.
2014
3月18日,参股浙江瑞邦药业股份有限公司
On March 18, the company took a stake in Zhejiang Ruibang Pharmaceutical Co.,Ltd.
4月,参股浙江博腾药业有限公司
In April, the company took a stake in Zhejiang Porton Pharmaceutical Co.,Ltd.
2015
5月15日,成立宣城美诺华药业有限公司
On May 15, Xuancheng Menovo Pharmaceutical Co.,Ltd. was set up.
9月,成立印度柏莱诺华药业有限公司
In September, Biomenovo Researce Private Limited was set up.
2017
4月7日,美诺华在上交所A股上市
On April 7, Menovo listed on Shanghai Stock Exchange.
11月1日,美诺华正式控股浙江燎原药业股份有限公司
On November 1, Menovo controlled Zhejiang Liaoyuan Pharmaceutical Co.,Ltd.
11月15日,成立宁波科尔康美诺华药业股份有限公司
On November 15, Ningbo Krka Menovo Pharmaceutical Co.,Ltd. was set up.
2018
4月11日,与上海锐合资产管理有限公司等四家签署合作协议参股“宁波美诺华锐合股权投资合伙企业(有限合伙)”
On April 11, the company signed cooperation agreements with Shanghai Ruihe Asset Management Co.,Ltd and other four companies to participate in the “Ningbo Menovo Ruihe Equity Investment Partnership (limited partnership)”.
2020
3月16日,成立宁波美诺华医药科技有限公司
On March 16, Ningbo Menovo Pharmaceutical Technology Co.,Ltd. was set up.
7月30日,收购宁波高新区美诺华医药创新研究院有限公司100%股权
On July 30, it acquired 100% of the equity of Ningbo high tech Zone Menovo Pharmaceutical Innovation Research Institute Co., Ltd.